Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
426 Ergebnisse
| FE58VL | Vertex Pharmaceuticals Inc./OS/Call [540]/SOC | - | - | 540,000 | call | Vertex Pharmaceuticals Inc. | - | 38,965 % | 0,551 | -0,064 | 3,280 | 21.01.2028 | 0,100 | Société Générale | ||
| GU8N65 | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 36,192 % | 0,217 | -0,115 | 12,897 | 18.09.2026 | 0,100 | Goldman Sachs | ||
| GW319X | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 39,439 % | 0,538 | -0,064 | 3,290 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| GW31A2 | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 36,494 % | 0,382 | -0,094 | 6,450 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GW319Z | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 37,374 % | 0,427 | -0,086 | 5,304 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW31CG | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 36,837 % | 0,467 | -0,076 | 4,525 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW97TA | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 35,585 % | 0,352 | -0,096 | 7,329 | 18.12.2026 | 0,100 | Goldman Sachs | ||
| GW97Y1 | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 34,579 % | 0,265 | -0,104 | 10,587 | 16.10.2026 | 0,100 | Goldman Sachs | ||
| GW980E | Vertex Pharmaceuticals Inc./OS/Call [550]/GOLDS | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 41,678 % | 0,160 | -0,144 | 16,532 | 21.08.2026 | 0,100 | Goldman Sachs | ||
| MJ8K5R |  | Vertex Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 39,269 % | 0,373 | -0,011 | 6,574 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MK9KV1 | | Vertex Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 40,401 % | 0,481 | -0,008 | 4,138 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MM7P4T | | Vertex Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 42,791 % | 0,262 | -0,015 | 10,444 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MN04AG | | Vertex Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 43,010 % | 0,543 | -0,007 | 3,147 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MN6FTC | | Vertex Pharmaceuticals Inc./OS/Call [550]/MS | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 40,236 % | 0,442 | -0,009 | 4,914 | 19.03.2027 | 0,010 | Morgan Stanley | |
| SX5KSP | Vertex Pharmaceuticals Inc./OS/Call [550]/SOC | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 37,814 % | 0,230 | -0,125 | 12,171 | 18.09.2026 | 0,100 | Société Générale | ||
| FA53KB | Vertex Pharmaceuticals Inc./OS/Call [550]/SOC | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 38,738 % | 0,371 | -0,105 | 6,670 | 18.12.2026 | 0,100 | Société Générale | ||
| FE58U7 | Vertex Pharmaceuticals Inc./OS/Call [550]/SOC | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 39,201 % | 0,504 | -0,071 | 3,768 | 17.09.2027 | 0,100 | Société Générale | ||
| FE58VB | Vertex Pharmaceuticals Inc./OS/Call [550]/SOC | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 38,854 % | 0,527 | -0,065 | 3,447 | 17.12.2027 | 0,100 | Société Générale | ||
| VY41Y1 | | Vertex Pharmaceuticals Inc./OS/Call [550]/VONT | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 38,836 % | 0,476 | -0,080 | 4,298 | 17.06.2027 | 0,100 | Vontobel | |
| VY58SL | | Vertex Pharmaceuticals Inc./OS/Call [550]/VONT | - | - | 550,000 | call | Vertex Pharmaceuticals Inc. | - | 38,464 % | 0,234 | -0,128 | 11,922 | 18.09.2026 | 0,100 | Vontobel | |
| GW92KX | Vertex Pharmaceuticals Inc./OS/Call [560]/GOLDS | - | - | 560,000 | call | Vertex Pharmaceuticals Inc. | - | 37,234 % | 0,403 | -0,084 | 5,450 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| JY0J9S | Vertex Pharmaceuticals Inc./OS/Call [560]/JPMD | - | - | 560,000 | call | Vertex Pharmaceuticals Inc. | - | 40,262 % | 0,353 | -0,107 | 6,570 | 18.12.2026 | 0,100 | JP Morgan | ||
| JY1U87 | Vertex Pharmaceuticals Inc./OS/Call [560]/JPMD | - | - | 560,000 | call | Vertex Pharmaceuticals Inc. | - | 40,461 % | 0,382 | -0,102 | 5,886 | 15.01.2027 | 0,100 | JP Morgan | ||
| JY30ED | Vertex Pharmaceuticals Inc./OS/Call [560]/JPMD | - | - | 560,000 | call | Vertex Pharmaceuticals Inc. | - | 42,778 % | 0,432 | -0,097 | 4,716 | 19.03.2027 | 0,100 | JP Morgan | ||
| SX5K5H | Vertex Pharmaceuticals Inc./OS/Call [560]/SOC | - | - | 560,000 | call | Vertex Pharmaceuticals Inc. | - | 38,849 % | 0,371 | -0,097 | 6,163 | 15.01.2027 | 0,100 | Société Générale | ||
| FE1AXR | Vertex Pharmaceuticals Inc./OS/Call [560]/SOC | - | - | 560,000 | call | Vertex Pharmaceuticals Inc. | - | 37,052 % | 0,333 | -0,097 | 7,216 | 18.12.2026 | 0,100 | Société Générale | ||
| FE1AXW | Vertex Pharmaceuticals Inc./OS/Call [560]/SOC | - | - | 560,000 | call | Vertex Pharmaceuticals Inc. | - | 39,281 % | 0,415 | -0,089 | 5,146 | 19.03.2027 | 0,100 | Société Générale | ||
| VH91A6 | | Vertex Pharmaceuticals Inc./OS/Call [560]/VONT | - | - | 560,000 | call | Vertex Pharmaceuticals Inc. | - | 38,222 % | 0,367 | -0,096 | 6,274 | 15.01.2027 | 0,100 | Vontobel | |
| GW95JG | Vertex Pharmaceuticals Inc./OS/Call [580]/GOLDS | - | - | 580,000 | call | Vertex Pharmaceuticals Inc. | - | 36,749 % | 0,356 | -0,080 | 5,773 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| JY1LSH | Vertex Pharmaceuticals Inc./OS/Call [580]/JPMD | - | - | 580,000 | call | Vertex Pharmaceuticals Inc. | - | 39,455 % | 0,326 | -0,094 | 6,383 | 15.01.2027 | 0,100 | JP Morgan | ||
| JY18HF | Vertex Pharmaceuticals Inc./OS/Call [580]/JPMD | - | - | 580,000 | call | Vertex Pharmaceuticals Inc. | - | 40,468 % | 0,379 | -0,089 | 5,201 | 19.03.2027 | 0,100 | JP Morgan | ||
| SX5K5J | Vertex Pharmaceuticals Inc./OS/Call [580]/SOC | - | - | 580,000 | call | Vertex Pharmaceuticals Inc. | - | 37,394 % | 0,312 | -0,087 | 6,791 | 15.01.2027 | 0,100 | Société Générale | ||
| FE1AXM | Vertex Pharmaceuticals Inc./OS/Call [580]/SOC | - | - | 580,000 | call | Vertex Pharmaceuticals Inc. | - | 37,727 % | 0,138 | -0,087 | 13,877 | 18.09.2026 | 0,100 | Société Générale | ||
| GJ8XF1 | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 36,543 % | 0,231 | -0,078 | 8,192 | 18.12.2026 | 0,100 | Goldman Sachs | ||
| GJ9UEX | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 36,292 % | 0,259 | -0,077 | 7,391 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GV70QS | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 40,209 % | 0,110 | -0,078 | 13,703 | 18.09.2026 | 0,100 | Goldman Sachs | ||
| GV87KD | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 35,935 % | 0,364 | -0,068 | 5,108 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW01FF | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 38,692 % | 0,462 | -0,062 | 3,580 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| GW1W77 | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 36,406 % | 0,312 | -0,074 | 6,090 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW82R8 | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 37,344 % | 0,147 | -0,076 | 11,518 | 16.10.2026 | 0,100 | Goldman Sachs | ||
| GW8MXZ | Vertex Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 49,325 % | 0,077 | -0,093 | 16,368 | 21.08.2026 | 0,100 | Goldman Sachs | ||
| JY2JGS | Vertex Pharmaceuticals Inc./OS/Call [600]/JPMD | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 41,833 % | 0,300 | -0,094 | 6,240 | 15.01.2027 | 0,100 | JP Morgan | ||
| MJ860W | | Vertex Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 40,528 % | 0,262 | -0,009 | 7,203 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MK9KV2 | | Vertex Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 40,017 % | 0,389 | -0,008 | 4,560 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MM5JP0 | | Vertex Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 49,325 % | 0,167 | -0,013 | 10,358 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MN04AH | | Vertex Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 41,988 % | 0,470 | -0,007 | 3,426 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MN6FTD | | Vertex Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 41,003 % | 0,342 | -0,009 | 5,340 | 19.03.2027 | 0,010 | Morgan Stanley | |
| SX5K5K | Vertex Pharmaceuticals Inc./OS/Call [600]/SOC | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 37,974 % | 0,273 | -0,082 | 6,991 | 15.01.2027 | 0,100 | Société Générale | ||
| SX5KSQ | Vertex Pharmaceuticals Inc./OS/Call [600]/SOC | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 41,035 % | 0,116 | -0,083 | 13,298 | 18.09.2026 | 0,100 | Société Générale | ||
| FE1AXX | Vertex Pharmaceuticals Inc./OS/Call [600]/SOC | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 38,692 % | 0,328 | -0,080 | 5,686 | 19.03.2027 | 0,100 | Société Générale |